New Market Report Now Available: Abbott Laboratories (ABT) -...
Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations.
Trending on the Topix Network
Thu Mar 13, 2014
Hampton Roads Daily Press
Suit: Prescription drug made Va. Beach cop psychotic, stab and shoot firefighters
That's what Virginia Beach police Officer Bradley Colas contends. Colas is suing AbbVie Inc. and Abbott Laboratories, saying that they knew their antibiotic Biaxin could cause manic behavior, hallucinations, paranoia and other psychological side effects, but didn't warn users properly.
ModernGraham Quarterly Valuation Of Abbott
Benjamin Graham taught that Intelligent Investors must do a thorough fundamental analysis of investment opportunities to determine their intrinsic value and inherent risk.
Wed Mar 12, 2014
US meal replacement market led by Abbott Laboratories when including...
Convalescence is expected to see tremendous growth in 2012 as the health benefits of the category start to resonate greatly with consumers.
The Financial Mirror
Research and Markets: Chinese Adalimumab ...
Adalimumab is a TNF inhibiting anti-inflammatory drug, the first fully human monoclonal antibody drug approved by the FDA.
Absolute Manage Customers can Streamline iOS Device Enrollment and Maintain Management of Devices
Customers have the ability to include mandatory Absolute Manage enrollment, ensuring devices cannot be removed from management.
Mon Mar 10, 2014
Abbott Laboratories Coverage Initiated by Analysts at Singular Research
The firm set a "sell" rating and a $30.00 price target on the stock. Singular Research's target price points to a potential downside of 24.18% from the stock's previous close.
Recent Study: Solvay Pharmaceuticals, Inc. - Pharmaceuticals &...
The company is principally engaged in providing blood screening tests for the in-vitro diagnostic markets.
Thu Mar 06, 2014
RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry
3D Bioprinting Market, 2014-2030 by Roots Analysis details the widespread optimism that bioprinting technology will rise dramatically in prominence in the coming years, impacting the daily lives of millions of people.
Wed Mar 05, 2014
The Motley Fool
Better Dividend: Abbott Laboratories vs. Medtronic, Inc.
Each stock also offers a reliable dividend, with both Medtronic and Abbott belonging to the S&P 500's Dividend Aristocrats, the group of companies that have raised their dividends annually for at least the past 25 years.
Mon Mar 03, 2014
UnitedHealth joint venture picks Medtronic for big stent contract
Hopsitals that are part of SharedClarity will now buy most of their stents from Medtronic Inc. and Abbott Laboratories.
Absolute Software Adds New Board Member
"Sal has an amazing depth of technology and business expertise, and we are delighted that he is joining Absolute's Board of Directors," said held a number of leadership positions within Infowave Software Inc. including Member of the Office of the President, Chief Technology Officer, and VP of Engineering.
Wed Feb 26, 2014
The Motley Fool
Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?
However, Abbott Laboratories was not the only Healthcare Equipment stock to be handsomely beaten by the S&P 500.
Mon Feb 24, 2014
Daily Dividend Report: K, ABT, SYY, AGU, PLL
This morning, Kellogg declared its quarterly dividend of 46 cents per share, maintaining the amount paid to shareholders the prior quarter.
Pensions & Investments
Abbott Laboratories eyes $300 million pension contribution
Abbott Laboratories plans to contribute about $400 million to its post-retirement plans in 2014, of which about $300 million will go to its main domestic pension fund.
Fri Feb 21, 2014
The Motley Fool
Can Boston Scientific Outperform the Index in 2014?
Indeed, the medical devices manufacturer has delivered a profit in only three of the last five years.
Abbott Laboratories - 10-K - Management's Discussion and Analysis of...
Financial Review Abbott's revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements.
Abbott Laboratories Plans Quarterly Dividend of $0.22
Abbott Laboratories announced a quarterly dividend on Friday, February 21st, AnalystRatings.Net reports.
Thu Feb 20, 2014
Insider Selling: Abbott Laboratories EVP Unloads 1,583 Shares of Stock
Abbott Laboratories EVP John C. Landgraf sold 1,583 shares of the company's stock in a transaction dated Tuesday, February 18th.